Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Oral treatment for multiple sclerosis
HTML
Details
Locations
Year:
2011
Type:
review
Source:
The Lancet Neurology
DOI:
10.1016/s1474-4422(11)70228-9
Authors:
Joep Killestein,
Richard A Rudick,
Chris H Polman
Institutions:
Amsterdam UMC Location Vrije Universiteit Amsterdam,
Cleveland Clinic
Language:
English
Topic:
Multiple Sclerosis Research Studies
Subfield:
Clinical Neurology
Field:
Medicine
Domain:
Health Sciences
Keywords:
relapsing-remitting multiple sclerosis,
oral disease-modifying therapy,
fingolimod,
cladribine,
teriflunomide,
laquinimod,
dimethyl fumarate,
mechanism of action,
drug efficacy,
drug safety,
neuroprotection,
breakthrough disease
show all 12
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2149021083
FWCI:
2.199
Cites:
59
Cited by:
106
Related to:
10